longlasting outcomes (PR, VGPR, CR) to mogamolizumab are possible and relatively frequentr in CTCL
Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes / Broccoli, A., Argnani, L., Pileri, A., Mazzoni, C., Sordi, B., Pimpinelli, N., Fava, P., Quaglino, P., Pennese, E., Perrone, T., Bernardelli, A., Visco, C., Teoli, M., Flenghi, L., Ibatici, A., Massone, C., Zinzani, P.L.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 1365-2141. - STAMPA. - 207:(2025), pp. 2578-2582. [10.1111/bjh.70161]
Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes
Pileri, Alessandro
;Mazzoni, Camilla
;Sordi, Benedetta
;Pimpinelli, Nicola;
2025
Abstract
longlasting outcomes (PR, VGPR, CR) to mogamolizumab are possible and relatively frequentr in CTCL
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Moga longlasting responses in CTCL BJH 2025.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
460.3 kB
Formato
Adobe PDF
|
460.3 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
